Capstone Investment Advisors
FOLD

Capstone Investment Advisors’s Amicus Therapeutics FOLD Stock Holding History

Capstone Investment Advisors’s Portfolio FOLD Stock Details FOLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-15,000
Closed -$226K – 1407
2020
Q2 		$226K Sell
15,000
-38,700
-72% -$472K ﹤0.01% 1207
2020
Q1 		$496K Buy
53,700
+15,000
+39% +$143K 0.01% 890
2019
Q4 		$377K Buy
+38,700
New +$354K ﹤0.01% 1189

Other funds holding FOLD

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return

Capstone Investment Advisors's FOLD Position: Q2 2026 in Review

Capstone Investment Advisors sold out of Amicus Therapeutics (FOLD) in Q2 2026, closing a stake of 265,730 shares — an estimated $3.84M sold.

Capstone Investment Advisors first reported a position in FOLD in Q2 2016 and held it in 11 quarters. The position peaked at $26.3M in Q4 2025. 2 funds tracked by Wall St. Rank hold FOLD as of Q2 2026.

  • Capstone Investment Advisors reported no remaining Amicus Therapeutics position as of Q2 2026 after selling out during the quarter.
  • Capstone Investment Advisors sold 265,730 Amicus Therapeutics shares in Q2 2026, an estimated $3.84M.
  • Capstone Investment Advisors first reported a position in Amicus Therapeutics in Q2 2016 and held it in 11 quarters.
  • Capstone Investment Advisors's Amicus Therapeutics position peaked at $26.3M in Q4 2025.
  • 2 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q2 2026.

Based on Capstone Investment Advisors's 13F filing for Q2 2026, filed 17 Aug 2026.